KPV
A small daily shot that calms an angry gut or itchy, inflamed skin. The quiet piece people add when a healing stack is not enough.
What it is
KPV is for the person whose gut is always a little inflamed, bloated after most meals, loose or cramping on bad weeks, or whose skin flares with eczema, psoriasis or slow-healing spots. It is three amino acids cut from the tail of a natural calming hormone, and its one job is turning down inflammation without the pigment or hormone effects of the parent.
Who actually runs it: people with IBS-type guts that react to everything, people with diagnosed IBD who want something alongside their medication, and people with eczema, rosacea or psoriasis that medicine controls but never quite clears. It is also the usual third piece next to BPC-157 and TB-500 when a joint is hot and swollen rather than just weak, and it stacks with GHK-Cu in skin routines. If your problem is a torn tendon or a leaky gut lining rather than inflammation, BPC-157 is the rebuild tool; KPV is the calming tool.
What you will notice, and when: for the gut, most people feel the first difference inside one to two weeks as less bloating after meals and calmer mornings; the bigger shift, fewer bad days and less urgency, lands around week four to six. For skin, itch tends to drop before redness does, a couple of weeks ahead. Good at the end of eight weeks looks like a gut you stop thinking about. It will not fix a food intolerance you keep eating, and it is not a substitute for a biologic if you are on one.
How people run it: 500 mcg subQ once a day in belly fat, for 8 to 12 weeks, or as long as you need it. There is no tolerance or build-up reason to cycle it: stop or taper once things have settled, which also shows whether the calm holds, and many people with a chronic gut go back on when it flares. From a 10 mg vial mixed in 1 mL that is 5 units on an insulin syringe and 20 days per vial, so an 8 to 12 week run is three to five vials. The two mistakes: starting at 200 mcg and deciding it does nothing after two weeks (that tier is a tolerance check, not a treatment), and expecting it to rebuild damaged tissue. For a gut-only problem the 500 mcg oral tablets on the KPV Oral page are a fair alternative, since the peptide is unusually stable by mouth and acts on the gut lining directly.
The evidence, once: KPV is the C-terminal tripeptide of alpha-MSH, and in mouse colitis models, both injected and oral, it reliably cut inflammation and gut damage; in skin and wound models it reduced inflammatory signaling, and in the lab it also kills some bacteria and yeast. Human data is close to nothing. So the mechanism is well shown in animals, the use in people is practice and reports, and the risk profile so far is benign.
When it is not worth it: a healthy gut that is fine most days, or a structural injury where BPC-157 does the real work. Who should skip it: anyone with IBD on immune-suppressing drugs without telling their gastroenterologist, because adding an anti-inflammatory peptide muddies the picture their medication is managed on. If you want the gut rebuilt and calmed at once, run it with BPC-157; if skin is the only goal, GHK-Cu alone may be the better buy.
What people use it for
Gut inflammation and flares
Some evidenceIn mouse models of colitis, KPV given by injection or by mouth cut inflammatory signaling and tissue damage and sped recovery, and it did so even when delivered straight into the gut lining. That is consistent, repeated animal evidence for the use nearly everyone runs it for. Human data is user reports and clinic practice, so expect a meaningful calming effect, not a cure for IBD.
Eczema, psoriasis and slow-healing skin
Some evidenceKPV lowered inflammatory signaling in skin cell and wound models and is studied as a topical anti-inflammatory. People with itchy, flaring skin report the itch dropping within a couple of weeks. The evidence is lab and animal level; there is no controlled human skin trial.
Hot, swollen joints
Early daysThis is extrapolation from the anti-inflammatory mechanism rather than joint-specific research, but it is why KPV is the usual third piece next to BPC-157 and TB-500 when a joint is inflamed rather than just weak. Reports are good; studies on joints do not exist.
Bacteria and yeast
Early daysIn the lab, KPV has antimicrobial activity against some bacteria and Candida, which is part of why it interests people with gut dysbiosis. It is a test-tube finding, not a reason to use it instead of treatment for an infection.
How it works
- Used for gut issues and skin where inflammation is the driver
- A small fragment of a natural anti-inflammatory hormone
- Mostly animal and lab research so far
- Well tolerated in early use, but human data is limited
How people use it
Safety, in brief
Things people sometimes notice
- A small sore spot or redness where you inject
- Looser or firmer stools in the first week as the gut settles, which usually passes
- Mild tiredness for the first few days in some people
The full picture — stop signs and who should talk to a doctor first — is on the dosing guide.
Sources
The labels and studies behind this page. Each link opens the original on PubMed, DailyMed or ClinicalTrials.gov.
- PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation
- Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease
- Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway
- Antimicrobial effects of alpha-MSH peptides